Your browser doesn't support javascript.
loading
Brentuximab vedotin with chemotherapy for stage III or IV classical Hodgkin lymphoma (ECHELON-1): 5-year update of an international, open-label, randomised, phase 3 trial.
Straus, David J; Dlugosz-Danecka, Monika; Connors, Joseph M; Alekseev, Sergey; Illés, Árpád; Picardi, Marco; Lech-Maranda, Ewa; Feldman, Tatyana; Smolewski, Piotr; Savage, Kerry J; Bartlett, Nancy L; Walewski, Jan; Ramchandren, Radhakrishnan; Zinzani, Pier Luigi; Hutchings, Martin; Munoz, Javier; Lee, Hun Ju; Kim, Won Seog; Advani, Ranjana; Ansell, Stephen M; Younes, Anas; Gallamini, Andrea; Liu, Rachael; Little, Meredith; Fenton, Keenan; Fanale, Michelle; Radford, John.
Afiliação
  • Straus DJ; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: strausd@mskcc.org.
  • Dlugosz-Danecka M; Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland.
  • Connors JM; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Alekseev S; Petrov Research Institute of Oncology, St Petersburg, Russia.
  • Illés Á; University of Debrecen, Debrecen, Hungary.
  • Picardi M; Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy.
  • Lech-Maranda E; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Feldman T; John Theurer Cancer Center, Hackensack Meridian Health School of Medicine, Hackensack, NJ, USA.
  • Smolewski P; Medical University of Lodz, Poland.
  • Savage KJ; Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Bartlett NL; Washington University School of Medicine Siteman Cancer Center, St Louis, MO, USA.
  • Walewski J; Maria Sklodowska-Curie National Research Institute of Oncology, European Reference Network, Warszawa, Poland.
  • Ramchandren R; The University of Tennessee Graduate School of Medicine, Knoxville, TN, USA.
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università degli Studi, Bologna, Italy.
  • Hutchings M; Department of Haematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Munoz J; Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Lee HJ; University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kim WS; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Advani R; Department of Medicine, Division of Oncology, Stanford University, Stanford, CA, USA.
  • Ansell SM; Division of Hematology, Mayo Clinic, Rochester, MN, USA.
  • Younes A; Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; AstraZeneca Pharmaceuticals, LP Wilmington, DE, USA.
  • Gallamini A; Research Innovation and Statistics, Antoine-Lacassagne Cancer Centre, Nice, France.
  • Liu R; Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceuticals, Cambridge, MA, USA.
  • Little M; Millennium Pharmaceuticals, a wholly owned subsidiary of Takeda Pharmaceuticals, Cambridge, MA, USA.
  • Fenton K; Seagen, Bothell, WA, USA.
  • Fanale M; Seagen, Bothell, WA, USA.
  • Radford J; University of Manchester and the Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Lancet Haematol ; 8(6): e410-e421, 2021 Jun.
Article em En | MEDLINE | ID: mdl-34048680
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Brentuximab Vedotin Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica / Brentuximab Vedotin Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Haematol Ano de publicação: 2021 Tipo de documento: Article País de publicação: Reino Unido